FDA Inspection 680692 — Meda Pharmaceuticals Inc.
The FDA completed an inspection of Meda Pharmaceuticals Inc. on Sep 17, 2010 in Somerset, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 17, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Somerset, NJ (United States)
Additional details
Risk Evaluation and Mitigation Strategies (REMS)